Approved Study Database

Ref. No. Scientific Title Principal investigator
2024.449 Registry on Mavacamten treatment of obstructive hypertrophic cardiomyopathy: real-world practice in Hong Kong Chinese cohort Dr. KAM Kevin Ka Ho
甘嘉豪
2024.468 AI-Based Intima-Media Thickness Measurement for Cardiovascular Risk Assessment Prof. YAN Bryan Ping Yen
甄秉言
2024.450 A Multicentre, Prospective, Randomized, Open Label, Blinded-endpoint Trial to Optimize the Use of Intravenous Tenecteplase in Participants with Acute Ischemic Stroke Prof. LEUNG Thomas Wai Hong
2024.448 Active surveillance of hospitalized patients with laboratory-confirmed influenza cases in a tertiary teaching hospital in Hong Kong Prof. LAI Christopher Koon Chi
2024.549 Validation of the MRI-based Alzheimer’s Disease Resemblance Atrophy Index and Plasma-Based Biomarkers on Alzheimer’s Disease Prof. MOK Vincent Chung Tong
2024.466 A Randomised, Double-blind, Placebo-controlled, Multi-centre, Sequential Phase II, and Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 Administered for up to 52 Weeks in Participants with Dyslipidaemia Prof. LUK Andrea On Yan
2024.460 A Phase 2b, multi-centre, randomized, partially placebo-controlled, double-blind study to investigate the safety and efficacy of sequential therapy with daplusiran/tomligisiran followed by bepirovirsen in participants with chronic hepatitis B virus on background nucleos(t)ide analogue therapy (B-United) Professor Wong Grace
2024.462 Inhomogeneous magnetization transfer imaging for assessing neurological and psychological disorders Prof CHU Winnie Chiu-wing
2024.446 Validation of 3D Reconstruction Algorithm and Automated Measurements of 3D Spinal Images Bases on Posteroanterior and Lateral Radiographs on Children with Adolescent Idiopathic Scoliosis Prof. CHU Winnie Chiu-wing
2024.456 A Phase 2, Open-Label, Single-Arm Study of Amivantamab and Lazertinib Combination Therapy as First-Line Treatment in Patients with EGFR-Mutated Recurrent Non-Small Cell Lung Cancer after Previous Treatment with Adjuvant Osimertinib in Early-Stage Disease Dr. LI Molly Siu Ching
2024.474 Educational needs and accuracy in electrocardiogram recognition of ambulance paramedics in Hong Kong: A Cross-Sectional Survey Mr. LAM Wing Fung
2024.454 Argon Beam Plasma Coagulation versus Formalin Instillation in Radiation Proctitis: A Randomized Controlled Trial Dr. LIU Yuk Ho
2024.461 Translating non-invasive non-contrast spin-lock magnetic resonance imaging for tissue characterization in routine clinical diagnosis Prof. CHEN Weitian
2024.478 Gaps in Awareness of Cardiovascular Diseases: A Cross Sectional Study Professor Yan Ping Yen Bryan
2024.438 Re-Defining Standard of Care – Heart Failure and Fluid Assessment Dr. KAM Kevin Ka Ho
2024.453 Effectiveness of the adoption of HA Go on reducing default rate, health service utilization, and adverse clinical outcomes: a retrospective cohort study Prof. HUANG Junjie
2024.441 A Phase 2, Open-label Study Evaluating STRO-002, an Anti-folate Receptor Alpha (FOLR1) Antibody-Drug Conjugate, in Subjects with Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer Expressing FOLR1 Dr. LOONG Herbert Ho Fung
2024.440 A Phase III double-blind, randomised, placebo-controlled trial to evaluate liver-related clinical outcomes and safety of once weekly injected survodutide in participants with compensated non-alcoholic steatohepatitis/metabolic dysfunction associated steatohepatitis (NASH/MASH) cirrhosis Prof. WONG Vincent Wai Sun
Wai Sun Vincent Wong
2024.471 IgG4-related disease: a multi-centre retrospective cohort study in Hong Kong Mr. YIP Carson Chun Yin
葉峻言
2024.480 Dysregulated Host - Gut Microbiota Co-Metabolism in Metabolic dysfunction-associated steatotic liver disease (MASLD) Prof. KONG Alice Pik Shan
江碧珊
2024.475 THE LEVEL OF KNOWLEDGE, AWARENESS, AND PRACTICE (KAP) OF SAFETY & EMERGENCY RESPONSE AMONG RECREATIONAL SCUBA DIVERS IN HONG KONG Mr. LAU Kwok Ho
2024.435 Treatment, Disabilities and Cost-effectiveness Analysis of von Hippel-Lindau Syndrome Patients – A Retrospective Cohort Study Dr. LEUNG Ka Wai
2024.469 Towards short dipolar relaxation time quantification via inhomogeneous magnetization transfer Prof. CHU Winnie Chiu-wing
2024.436 Outcomes of Conversion Gastrectomy in Metastatic Gastric Cancer Dr. CHAN Shannon Melissa
陳詩瓏
2024.451 A randomised, double-blind, placebo-controlled, multicentre, Phase III trial evaluating long-term efficacy and safety of survodutide weekly injections in adult participants with non-cirrhotic non-alcoholic steatohepatitis/metabolic associated steatohepatitis (NASH/MASH) and (F2) - (F3) stage of liver fibrosis Prof. WONG Vincent Wai Sun
Wai Sun Vincent Wong
2024.472 The application of acupuncture in obstetrics and gynecological procedures: Attitude among different individuals in Hong Kong Dr. CHUNG Jacqueline Pui Wah
2024.437 Review of non-nasopharyngeal lymphoepithelial carcinoma in the head and neck Dr. LEUNG Ho Sang
2024.470 Enhancing Supraglottic Airway Management in cardiopulmonary resuscitation for Paramedics in Hong Kong - A randomised crossover manikin study on the two Supraglottic airway devices: LMA-Supreme™and i-gel®. Mr. LEE Kong Hang
李港衡
2024.447 The Effectiveness of A Theory-based Health Behaviour Change Intervention on Waist Circumference and Kidney Function in Patients of Metabolic Syndrome with Chronic Kidney Disease: A Randomised Controlled Trial Ms YAN LIN JIA
2024.476 Predictors of 1-year re-hospitalization among adult patients with substance use disorders in a psychiatric center in Hong Kong Dr Wong Wai tsun
2024.432 Flexible Ureterorenoscopy for Surveillance of Upper Tract Urothelial carcinoma-A pilot study Prof. TEOH Yuen Chun
2024.439 A Validation Study of the Hong Kong Version of the Personal Impact of Epilepsy Scale (HK-PIES) for People with Epilepsy in Hong Kong Dr. CHAN Cheuk Him Charlie
2024.429 A Phase 2b/3, Multi-part, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Atacicept in Subjects with IgA Nephropathy (IgAN) Prof. SZETO Cheuk Chun
2024.430 Cardio- and Cerebrovascular Disease Biobank for Research Dr. IP Bonaventure Yiu Ming
2024.425 An Open-Label, Multicenter, Phase 1 Study of AN4005 in Patients with Advanced Tumors Dr. LOONG Herbert Ho Fung
2024.459 Enhancing Cardiometabolic Health in Postnatal Women at High-Risk for Preeclampsia Through Exercise Intervention Prof. POON Chiu Yee Liona
2024.428 The disease burden of RSV infection in Hong Kong Prof. HUI David Shu Cheong
2024.418 An evaluation of the effectiveness and cost-effectiveness of the Chronic Disease Co-Care (CDCC) Pilot Scheme: a commissioned study Dr Leung Shuk Yun
2024.477 Clinical Characteristics of Patient with Tumour Induced Osteomalacia in Hong Kong Dr. OZAKI Risa
2024.421 Validation of a breath-based test in predicting response of carvedilol in patients with compensated advanced chronic liver disease Dr. LAI Jimmy Che To
Grace LH Wong
2024.427 Risk factors associated with Multi-drug resistant organisms (MDRO) carrier status in three Residential Care Homes for the Elderly (RCHE) in Tai Po district Dr LEUNG Siu Tung Stephanie
2024.412 Comparison of Acute Kidney Injury Risk Prediction Scores after Aortic and Cardiac Surgery Dr. LEE Christopher P.T.
2024.417 Assessing Cancer Risk and Comorbidities in Diabetic vs. Non-Diabetic Patients in Hong Kong: a retrospective cohort study Prof. HUANG Junjie
2024.416 Independent double-checking of medication in emergency departments of hospitals: A sequential mixed-methods design Professor Lau Ying
2024.411 Effect of feedback devices on chest compression quality in Hong Kong nurses: A cross-over manikin study Mr. LEE Wai Yat
李瑋日
2024.398 Adjunctive Fludrocortisone in Septic Shock: a multicenter, double-blind, randomized, placebo-controlled pilot trial (AFLUDROS-1) Dr LING Lowell
2024.400 Emergency Stroke Unit for Acute Cerebrovascular Events: A Prospective, Single-arm Trial with a Historical Control Group Professor Leung Wai Hong Thomas
2024.395 Non-curative ESDs: Assessing the Rates and Risk Factors for Residual Neoplasia Dr. YIP Hon Chi
葉瀚智
2024.407 Measuring the neural markers of hearing and spatial hearing in normal hearing and hearing impaired using functional near-infrared spectroscopy and electroencephalography Dr. SCHNUPP Jan
2024.389 Community burden of Mycoplasma genitalium infection and its implications for test-and-treat strategies Prof. WONG Ngai Sze

Page 2 of 255.